Skip to content

To study the effect of unani medicine in Pelvic inflammatory disease

Therapeutic evaluation of unani formulation in management of Pelvic inflammatory disease (Warm-e-aza-e-ana) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068614
Enrollment
30
Registered
2024-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N74- Female pelvic inflammatory disorders in diseases classified elsewhere

Interventions

Intervention1: 1.Arq-E-Baranjasif 2.Vaginal Pessary: 1. Arq-E-Baranjasif, PO, 60 Ml, BD for 3 months 2. Vaginal Pessary for 3 months Control Intervention1: NIL: NIL

Sponsors

Government nizamia tibbi college and general hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women of reproductive age i.e, 20 years - 40 years 2. Married and Non-Pregnant women 3. USG reports suggestive of Pelvic Inflammatory Disease

Exclusion criteria

Exclusion criteria: 1. Patient Suffering From Pelvic Inflammatory Disease With Surgical Emergency 2. Pregnant Women and Lactating Women 3. Patients with Appendicitis, Septic Abortions and Ovarian Cyst. 4. Women With Serious Medical Illness, CVD, Respiratory Diseases, Renal Disorders, TB. 5. Women With Serious Gynaecological Disorder like Pelvic Carcinoma and Systematic Disease.

Design outcomes

Primary

MeasureTime frame
Change in Subjective Parameters Like Abnormal White Discharge, Lower Abdominal Pain, Nausea and Vomiting, Fever with chills, Dyspareunia and DysuriaTimepoint: At baseline and every 30th day for 3 months

Secondary

MeasureTime frame
Change in Congested Cervix, purulent Discharge, Tenderness in Both Quadrants Of Lower Abdomen, On P/V decreased Abnormal Vaginal DischargeTimepoint: At baseline (0th day), 30th day, 60th day and 90th day

Countries

India

Contacts

Public ContactDr Roohina Jabeen

Government Nizamia Tibbi College And General Hospital

syedaabidunnisa@gmail.com9492027082

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026